These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36883900)

  • 1. A chlorogenic acid functional strategy of anti-inflammation, anti-coagulation and promoted endothelial proliferation for bioprosthetic artificial heart valves.
    Chen X; Yu T; Kong Q; Xu H; Zhao Z; Li G; Fan H; Wang Y
    J Mater Chem B; 2023 Mar; 11(12):2663-2673. PubMed ID: 36883900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
    Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
    Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
    Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
    Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A versatile drug-controlled release polymer brush hybrid non-glutaraldehyde bioprosthetic heart valves with enhanced anti-inflammatory, anticoagulant and anti-calcification properties, and superior mechanical performance.
    Yu T; Li G; Chen X; Kuang D; Jiang Q; Guo Y; Wang Y
    Biomaterials; 2023 May; 296():122070. PubMed ID: 36868031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioprosthetic heart valve cross-linked by a non-glutaraldehyde reagent with improved biocompatibility, endothelialization, anti-coagulation and anti-calcification properties.
    Yu T; Yang W; Zhuang W; Tian Y; Kong Q; Chen X; Li G; Wang Y
    J Mater Chem B; 2021 May; 9(19):4031-4038. PubMed ID: 33908590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synergistic strategy of dual-crosslinking and loading intelligent nanogels for enhancing anti-coagulation, pro-endothelialization and anti-calcification properties in bioprosthetic heart valves.
    Hu M; Shi S; Peng X; Pu X; Yu X
    Acta Biomater; 2023 Nov; 171():466-481. PubMed ID: 37793601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-crosslinked bioprosthetic heart valves prepared by glutaraldehyde crosslinked pericardium and poly-2-hydroxyethyl methacrylate exhibited improved antithrombogenicity and anticalcification properties.
    Huang X; Zheng C; Ding K; Zhang S; Lei Y; Wei Q; Yang L; Wang Y
    Acta Biomater; 2022 Dec; 154():244-258. PubMed ID: 36306983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(2-methoxyethyl acrylate) coated bioprosthetic heart valves by copolymerization with enhanced anticoagulant, anti-inflammatory, and anti-calcification properties.
    Liang X; Lei Y; Ding K; Huang X; Zheng C; Wang Y
    J Mater Chem B; 2022 Dec; 10(48):10054-10064. PubMed ID: 36448545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
    Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
    Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visible light-induced cross-linking of porcine pericardium for the improvement of endothelialization, anti-tearing, and anticalcification properties.
    Yang F; Xu L; Guo G; Wang Y
    J Biomed Mater Res A; 2022 Jan; 110(1):31-42. PubMed ID: 34245103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synergistic strategy based on active hydroxymethyl amine compounds and fucoidan for bioprosthetic heart valves with enhancing anti-coagulation and anti-calcification properties.
    Pu H; Wang C; Yu T; Chen X; Li G; Zhu D; Pan X; Wang Y
    Int J Biol Macromol; 2024 May; 266(Pt 2):130715. PubMed ID: 38462108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
    Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
    Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves.
    Liu X; Yu K; Cheng S; Ren T; Maitusong M; Liu F; Chen J; Qian Y; Xu D; Zhu G; Fang J; Cao N; Wang J
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112337. PubMed ID: 34474888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialdehyde pectin-crosslinked and hirudin-loaded decellularized porcine pericardium with improved matrix stability, enhanced anti-calcification and anticoagulant for bioprosthetic heart valves.
    Hu M; Peng X; Zhao Y; Yu X; Cheng C; Yu X
    Biomater Sci; 2021 Nov; 9(22):7617-7635. PubMed ID: 34671797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PEGylation method of fabricating bioprosthetic heart valves based on glutaraldehyde and 2-amino-4-pentenoic acid co-crosslinking with improved antithrombogenicity and cytocompatibility.
    Ding K; Zheng C; Huang X; Zhang S; Li M; Lei Y; Wang Y
    Acta Biomater; 2022 May; 144():279-291. PubMed ID: 35365404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine-grafted porcine pericardium by copolymerization to improve the cytocompatibility, hemocompatibility and anti-calcification properties of bioprosthetic heart valve materials.
    Liang X; Zheng C; Ding K; Huang X; Zhang S; Lei Y; Yu K; Wang Y
    J Mater Chem B; 2022 Jul; 10(29):5571-5581. PubMed ID: 35791926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart Valves Cross-Linked with Erythrocyte Membrane Drug-Loaded Nanoparticles as a Biomimetic Strategy for Anti-coagulation, Anti-inflammation, Anti-calcification, and Endothelialization.
    Hu C; Luo R; Wang Y
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41113-41126. PubMed ID: 32833422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free-aldehyde neutralized and oligohyaluronan loaded bovine pericardium with improved anti-calcification and endothelialization for bioprosthetic heart valves.
    Liu Y; Chen C; Lu T; Liu S; Wu Z; Tang Z
    Front Bioeng Biotechnol; 2023; 11():1138972. PubMed ID: 37077226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic-modified bioprosthetic heart valves with Cysteine-Alanine-Glycine peptide for anti-thrombotic, endothelialization and anti-calcification.
    Liang X; Yang L; Lei Y; Zhang S; Chen L; Hu C; Wang Y
    Int J Biol Macromol; 2023 Oct; 250():126244. PubMed ID: 37562473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosslinking porcine aortic valve by radical polymerization for the preparation of BHVs with improved cytocompatibility, mild immune response, and reduced calcification.
    Xu L; Yang F; Ge Y; Guo G; Wang Y
    J Biomater Appl; 2021 Apr; 35(9):1218-1232. PubMed ID: 33478311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.